slides · global inventory
Analyze Data
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 58,039
Current window 25,201-25,230
Pages 1,935
Rows per page 30
Slide function
25,201-25,230 of 58,039
29
Includes pro forma adjustments for the Culture Kings acquisition.a.k.a. Brands | IPO Presentation Deck | 45 slides · a.k.a. Brands
Pitch deck Investment bank Beat · Traction1 hit
30
The table highlights significant growth in sales and gross profit, alongside margin expansion and EBITDA changes.a.k.a. Brands | IPO Presentation Deck | 45 slides · a.k.a. Brands
Pitch deck Investment bank Beat · Traction1 hit
32
The slide presents financial performance metrics for a.k.a. Brands.a.k.a. Brands | IPO Presentation Deck | 45 slides · a.k.a. Brands
Pitch deck Investment bank Beat · Financials1 hit
33
Includes pro forma adjustments for IPO and acquisition.a.k.a. Brands | IPO Presentation Deck | 45 slides · a.k.a. Brands
Pitch deck Investment bank Beat · Financials1 hit
43
Includes a footnote explaining the LTM Q2'21PF calculation methodology.a.k.a. Brands | IPO Presentation Deck | 45 slides · a.k.a. Brands
Pitch deck Investment bank 1 hit
44
a.k.a. Brands | IPO Presentation Deck | 45 slidesa.k.a. Brands | IPO Presentation Deck | 45 slides · a.k.a. Brands
Pitch deck Investment bank 1 hit
45
LTM calculation methodology provided in footnote.a.k.a. Brands | IPO Presentation Deck | 45 slides · a.k.a. Brands
Pitch deck Investment bank 1 hit
21
Includes CAGR calculations for key metrics.AlTi | SPAC Presentation Deck | 33 slides · Alvarium Tiedemann Capital
Pitch deck Investment bank 1 hit
24
Includes detailed footnotes regarding share earnouts, redemptions, and adjustments to enterprise value.AlTi | SPAC Presentation Deck | 33 slides · Alvarium Tiedemann Capital
Pitch deck Investment bank 1 hit
18
The slide uses two different chart types (line and bar) to illustrate consumer sentiment trends and specific purchase drivers.Asos | Investor Day Presentation Deck | 56 slides · ASOS
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
19
The slide uses a dual bar chart to contrast negative drivers (buy less) and positive drivers (buy more).Asos | Investor Day Presentation Deck | 56 slides · ASOS
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
10
Standard clinical trial patient flow diagram.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
11
Waterfall plots show best percentage change in sum of diameters from baseline for two treatment arms.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
12
Kaplan-Meier survival analysis plot with a risk table below.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
13
Kaplan-Meier survival analysis plot with a risk table at the bottom.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
14
Clinical trial data presentation; includes 'Patients Still at Risk' table and statistical summary.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
15
The table compares safety profiles of two drugs across various adverse event categories.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
16
Includes footnotes regarding patient exclusions and definitions of LVEF events.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
23
Slide presents two distinct clinical trial visualizations: a Kaplan-Meier survival curve and a waterfall plot.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations Beat · Market Size1 hit
25
The slide presents two distinct clinical data sets: a table for PACIFIC-R and a Kaplan-Meier survival curve for the COAST trial.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations Beat · Market Size1 hit
26
Slide displays multiple clinical trial results (Kaplan-Meier curves and waterfall plots) across different drug combinations.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations 1 hit
33
Includes a table of clinical outcomes (PFS-10 months, ORR) and a risk table at the bottom.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations 1 hit
20
The slide uses two donut charts to segment revenue and lists three key metrics for geographic/distribution coverage.Azek | Investor Presentation Deck | 37 slides · The AZEK Company
Pitch deck Investor relations 1 hit
33
Includes LTM Q3 2021 and YTD Q3 2020/2021 comparisons. Adjusted RONTA definition provided in footnote.Azek | Investor Presentation Deck | 37 slides · The AZEK Company
Pitch deck Investor relations 1 hit
34
Contains two distinct financial tables with detailed footnotes explaining non-GAAP adjustments.Azek | Investor Presentation Deck | 37 slides · The AZEK Company
Pitch deck Investor relations 1 hit
36
Contains two primary tables: Adjusted Net Income Reconciliation and Adjusted Diluted EPS Reconciliation, with 10 numbered footnotes explaining adjustments.Azek | Investor Presentation Deck | 37 slides · The AZEK Company
Pitch deck Investor relations 1 hit
05
Includes detailed footnotes regarding share counts, earnout structures, and valuation assumptions.Babylon | Investor Presentation Deck | 42 slides · Babylon
Pitch deck Investor relations 1 hit
27
The slide uses a table-like structure to compare business models and their associated financial performance metrics.Babylon | Investor Presentation Deck | 42 slides · Babylon
Pitch deck Investor relations Beat · Business Model1 hit
28
The chart illustrates the divergence between revenue growth and cost metrics, highlighting operational leverage.Babylon | Investor Presentation Deck | 42 slides · Babylon
Pitch deck Investor relations Beat · Business Model1 hit
30
The slide uses donut charts to visualize revenue composition shifts over a two-year period.Babylon | Investor Presentation Deck | 42 slides · Babylon
Pitch deck Investor relations Beat · Business Model1 hit